Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries
Year: 2013
Type: article
Study design: Observational Study
Abstract: Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries
Source: Haematologica
Institutions: Università Cattolica del Sacro Cuore, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne, Azienda Ospedaliero Universitaria San Giovanni Battista, Azienda Ospedaliera Universitaria Integrata Verona, Policlinico Umberto I, University of Würzburg, Universitätsklinikum Würzburg, Hôpitaux Universitaires de Strasbourg, Hôpital d'Hautepierre, Innsbruck Medical University, Universität Innsbruck, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Masaryk University, Central European Institute of Technology – Masaryk University, University Hospital Brno, Robert Koch Institute, McGill University, Universitätsklinikum des Saarlandes, University of Udine
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
Funders: Pfizer, Gilead Sciences, Viropharma, Celgene, McGill University, Deutsches Zentrum für Infektionsforschung, BioCryst, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Bundesministerium für Bildung und Forschung, Astellas Pharma, Universität des Saarlandes, Central European Institute of Technology, Universität zu Köln, Julius-Maximilians-Universität Würzburg, Masarykova Univerzita, Universitätsklinikum Köln, Robert Koch Institut, Merck Sharp and Dohme, Pfizer Pharmaceuticals
OpenAlex ID: W2125502424